Christie Medical Holdings, Inc., and B. Braun Medical Announce Collaboration Aimed at Improving Peripheral IV Access Success

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

April 27, 2017

Christie Medical Holdings, Inc., with its market-leading vein finder technology, VeinViewer® system, today announced an alliance with B. Braun Medical Inc., a leader in infusion therapy and pain management.

Intravenous (IV) therapy plays a central role in patient care with as many as 90 percent of hospital patients receiving a peripheral IV catheter as part of their treatment plan. Many hospitals are adopting technology to improve the placement, safety, and duration for peripheral IV access. The combination of VeinViewer by Christie and B. Braun Medical’s line of IV products – such as the Introcan Safety® IV catheter, STEADYCare extension set with Wedge catheter stabilizer – aims to provide an innovative solution to enhance peripheral IV catheter access success.

“Aligning the VeinViewer technology with one of the top companies in the United States’ peripheral IV catheter market provides our customers with a seamless solution for improving peripheral IV access,” said George Pinho, president of Christie Medical Holdings. “B. Braun’s extensive coverage across the U.S. hospital market and excellent reputation will enable us to work together to serve more customers with VeinViewer and the Introcan Safety IV Catheter. More importantly, health care providers and patients will be the primary beneficiaries of this strategic alliance.”

VeinViewer reduces the time needed for IV insertion and improves first stick success when starting an IV catheter, ultimately improving the patient experience. VeinViewer allows nurses to clearly see peripheral veins as a real-time, high-definition image directly on the surface of the patient’s skin. With VeinViewer technology, hospitals recognize the benefit of increased success in obtaining peripheral IV access, reduced use of central lines and increased cost savings.

B. Braun’s Introcan Safety IV catheter complements the VeinViewer system, because it offers passive safety through an innovative solution that addresses accidental needlestick injury.

Additionally, B. Braun’s STEADYCare extension set with Wedge catheter stabilizer is designed to minimize catheter movement in the vessel, support the catheter insertion angle, and reduce the patient connector’s skin contact, helping to reduce catheter-related complications.

“These technologies are intended to work together to improve placement, insertion, duration and safety associated with peripheral IV catheter therapy,” said Tom Sutton, B. Braun Medical’s Vice President of Marketing for IV Systems, Vascular Access and Pharmacy Admixture Products. “The VeinViewer technology is an excellent addition to our infusion therapy product line, because it addresses the first critical step in peripheral IV therapy success by helping the clinician select the best vein for placing an IV catheter. Our hospital customers are seeking solutions to improve the patient experience associated with peripheral IV access. This collaboration helps us achieve that.”

As part of the alliance, B. Braun and Christie will focus on bringing VeinViewer to all hospitals in the United States. B. Braun will be the exclusive distributor of VeinViewer in the United States. Christie will continue to sell VeinViewer to Veterans Affairs hospitals, outpatient facilities, vein clinics, and educational centers, such as nursing schools. Christie also will continue to manage its international distribution partners.

All VeinViewer customers — regardless of where they buy their VeinViewer — will continue to receive service through Christie. Additionally, Christie will continue offering educational programs as described in the Christie Assure Program, including Christie University, tele-training and Assure Clinical Educators.

* VeinViewer is a registered trademark of Christie Medical Holdings, Inc.

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.